Results 181 to 190 of about 109,382 (263)
In patients with esophageal squamous cell carcinoma receiving definitive radiotherapy combined with systemic therapy, posttreatment TP53 mutation clearance and ctDNA‐MRD negativity predict favorable outcomes, whereas persistent ctDNA signals indicate elevated relapse risk, supporting nucleosome‐ and MRD‐informed surveillance and risk‐stratification ...
Shutang Liu +9 more
wiley +1 more source
Therapeutic Vulnerabilities of the Key Genetic Drivers in Leiomyosarcoma. [PDF]
Lesovaya EA +7 more
europepmc +1 more source
The lichen‐derived metabolite methyl 4‐O‐demethylbarbatate (Me‐4‐O‐DBA) suppresses glioma stemness, motility, and metabolic plasticity through inhibition of HIF‐1α signaling and synergistically enhances temozolomide activity, highlighting a potential strategy to target stemness‐driven therapeutic resistance in glioma.
Rui Zhou +8 more
wiley +1 more source
A Spinal Cord Sarcoma With EWSR1::WT1 Fusion Exhibited Ewing Sarcoma-Like Pattern Rather Than Desmoplastic Small Round Cell Tumor. [PDF]
Zeng C, Wang Y.
europepmc +1 more source
Lactate and Lactylation: What We Know and What We Expect in Tumour Progression
Lactate and lactylation in cancer cells have been shown to accelerate tumour development in various ways, including stemness generation, metabolic dysregulation, cell death, chemotherapy resistance, and cell cycle disorder. In addition, lactate and lactylation promote angiogenesis and create an immunosuppressive microenvironment, which promotes tumour ...
Qi Zhang, Zhenzhen Han, Youjia Duan
wiley +1 more source
A Novel <i>TBC1D15::RAB21</i> Variant in T-Cell Acute Lymphoblastic Leukemia. [PDF]
Su Z, Zhong R, Zhao C.
europepmc +1 more source
Trim32 regulates the transition from proliferation to differentiation in C2C12 cells after myogenic induction. We found that, at the onset of differentiation, Trim32 destabilizes c‐Myc mRNA, promotes cell cycle exit, and enables normal myotube formation.
Lu Xiong +6 more
wiley +1 more source
In Vitro Chromosome Translocations: Modeling Critical Drivers of Human Neoplasms. [PDF]
Tynyshtykbayeva N +3 more
europepmc +1 more source
AML1-ETO oncogenic fusion protein; cyclooxygenase-2 (COX-2) [PDF]
openaire +1 more source
CD36‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems
Nutrient deprivation drives a lipid‐centric shift in tumour metabolic symbiosis and signalling network. CD36 functions as a bidirectional bridge, transferring fatty acids from stromal donors (adipocytes, CAFs) to the ecosystem tumour‐ and microenvironment‐dependently.
Anna Sebestyén +11 more
wiley +1 more source

